Is Clostridium botulinum neurotoxin a registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 2 valid registrations of Clostridium botulinum neurotoxin a, including XEOMIN 100 U Vial (100 U, powder for solution for injection, SAR 647.90); XEOMIN 50 U Vial (50 U, powder for solution for injection, SAR 323.95).

Active substance

Clostridium botulinum neurotoxin a

SFDA 2

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
XEOMIN 100 U Vial	100 U	powder for solution for injection · Intramuscular use	1 Vial	SAR 647.90	Biological · Prescription	MERZ PHARMACEUTICALS GMBH	Valid
XEOMIN 50 U Vial	50 U	powder for solution for injection · Intramuscular use	1 Vial	SAR 323.95	Biological · Prescription	MERZ PHARMACEUTICALS GMBH	Valid

Indications — CHI Daman Drug Formulary

BELL'S PALSY; HEMORRHOIDS; HUNTINGTON'S DISEASE-DYSTONIA; RAYNAUD'S PHENOMENON; SPASTICITY; TOURETTE SYNDROME

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.